Expressing and purifying an anti-atherosclerosis polypeptide vaccine in Escherichia coli

Protein Expression and Purification

Volumn 36, Issue 2, 2004, Pages 198-206

  Gaofu, Qi ^a   Jie, Wu ^a   Xin, Yang ^a   Roque, Rouel S ^b   Jingjing, Liu ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Antibody; Cholesteryl ester transfer protein; Expression and purification; Tetanus toxin; Vaccine

Indexed keywords

ASPARTIC ACID; BACTERIAL PROTEIN; CARRIER PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; GLYCOPROTEIN; HYBRID PROTEIN; HYDROCHLORIC ACID; PROLINE; SUBUNIT VACCINE; TETANUS TOXIN;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; ARTERIOSCLEROSIS; ARTICLE; CELL INCLUSION; CHEMISTRY; DIMERIZATION; ESCHERICHIA COLI; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ARTERIOSCLEROSIS; ASPARTIC ACID; BACTERIAL PROTEINS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; DIMERIZATION; ESCHERICHIA COLI; GLYCOPROTEINS; HUMANS; HYDROCHLORIC ACID; IMMUNIZATION; INCLUSION BODIES; MICE; MOLECULAR SEQUENCE DATA; PROLINE; RECOMBINANT FUSION PROTEINS; TETANUS TOXIN; VACCINES, SUBUNIT;

ESCHERICHIA COLI;

EID: 3142637526     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.04.005     Document Type: Article

References (16)

1. Barter P., Rye K.A. Cholesteryl ester transfer protein: its role in plasma lipid transport. Clin. Exp. Pharmacol. P. 21:1994;663-672
2. Tall A.R. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J. Intern. Med. 237:1995;5-12
3. Whitlock M.E., Swenson T.L., Ramakrishnan R., Leonard M.T., Marcel Y.L., Milne R.W., Tall A.R. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit: effects on lipoprotein composition and elevated density lipoprotein cholesteryl ester metabolism. J. Clin. Invest. 84:1989;129-137
4. Gaynor B.J., Sand T., Clark R.W., Aiello R.J., Bamberger M.J., Moberrly J.B. Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition. Atherosclerosis. 110:1994;101-109
5. Asztalos B.F., Schaefer E.J. HDL in atherosclerosis: actor or bystander? Atheroscler. Suppl. 4:2003;21-29
6. Rittershaus C.W., Miller D.P., Thomas L.J., Picard M.D., Honan C.M., Emmett C.D., Pettey C.L., Adari H., Hammond R.A., Beattie D.T., Callow A.D., Marsh H.C., Ryan U.S. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20:2000;2106-2112
7. Zhang Y.K., Li T.M., Liu J.J Low temperature and glucose enhanced T7 RNA polymerase-based plasmid stability for increasing expression of glucagon-like peptide-2 in Escherichia coli. Protein Expr. Purif. 29:2003;132-139
8. Swenson T.L., Hesler C.B., Brown M.L., Quinet E., Trotta P.P., Haslanger M.F., Gaeta F.C., Marcel Y.L., Milne R.W., Tall A.R. Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope. J. Biol. Chem. 264:1989;14318-14326
9. Panina-Borgignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:1989;2237-2242
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 72:1976;248-254
11. Jingjing L., Xue Y., Agarwal N., Roque R.S. Human muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 40:1999;752-759
12. Bruce C., Chouinard R.A., Tall A.R. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr. 18:1998;297-330
13. Kothari H., Poirier K., Lee W., Satoh Y. Inhibition of cholesteryl ester transfer protein by CGS 25159 and changes in lipoproteins in hamsters. Atherosclerosis. 128:1997;59-66
14. Sugano M., Makino N. Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits. J. Biol. Chem. 271:1996;19080-19083
15. Agellon L.B., Walsh A., Hayek T., Moulin P., Jiang X.C., Shelanski S.A., Breslow J.L., Tall A.R. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266:1991;10796-10801
16. Inazu A., Jiang X.C., Haraki T., Yagi K., Kamon N., Koizumi J., Mabuchi H., Takeda R., Takata K., Moriyama Y. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94:1994;1872-1882